What is the share price of Astec Lifesciences Ltd (ASTEC) today?
The share price of ASTEC as on 8th May 2026 is ₹710.70. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Astec Lifesciences Ltd (ASTEC) share?
The past returns of Astec Lifesciences Ltd (ASTEC) share are- Past 1 week: 2.85%
- Past 1 month: 29.69%
- Past 3 months: 11.75%
- Past 6 months: 15.11%
- Past 1 year: 9.07%
- Past 3 years: -46.82%
- Past 5 years: -38.54%
What are the peers or stocks similar to Astec Lifesciences Ltd (ASTEC)?
The peers or stocks similar to Astec Lifesciences Ltd (ASTEC) include:What is the market cap of Astec Lifesciences Ltd (ASTEC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Astec Lifesciences Ltd (ASTEC) is ₹1593.74 Cr as of 8th May 2026.What is the 52 week high and low of Astec Lifesciences Ltd (ASTEC) share?
The 52-week high of Astec Lifesciences Ltd (ASTEC) is ₹990.82 and the 52-week low is ₹513.40.What is the PE and PB ratio of Astec Lifesciences Ltd (ASTEC) stock?
The P/E (price-to-earnings) ratio of Astec Lifesciences Ltd (ASTEC) is -19.70. The P/B (price-to-book) ratio is 6.78.Which sector does Astec Lifesciences Ltd (ASTEC) belong to?
Astec Lifesciences Ltd (ASTEC) belongs to the Materials sector & Fertilizers & Agro Chemicals sub-sector.How to buy Astec Lifesciences Ltd (ASTEC) shares?
You can directly buy Astec Lifesciences Ltd (ASTEC) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Astec Lifesciences Ltd
ASTEC Share Price
NSE₹710.700.64% (-4.55)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
ASTEC Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ASTEC Performance & Key Metrics
ASTEC Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -19.70 | 6.78 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 29.12 | 3.45 | 2.07% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
ASTEC Company Profile
Astec LifeSciences Limited is a holding company. The Company is a producer of agrochemicals and pharmaceutical intermediates.
PE Ratio
1,439.59
1,439.59
1Y Return
14.76%
14.76%
Buy Reco %
0.00
0.00
COROMANDEL
PE Ratio
29.58
29.58
1Y Return
15.40%
15.40%
Buy Reco %
88.89
88.89
UPL
PE Ratio
61.28
61.28
1Y Return
1.60%
1.60%
Buy Reco %
80.00
80.00
BAYERCROP
PE Ratio
36.69
36.69
1Y Return
0.10%
0.10%
Buy Reco %
50.00
50.00
CHAMBLFERT
PE Ratio
11.03
11.03
1Y Return
34.04%
34.04%
Buy Reco %
100.00
100.00
ASTEC Forecast
ASTEC Forecasts
Price
Revenue
Earnings
ASTEC Share Price Forecast
ASTEC Share Price Forecast
2026
Current
₹710.70
Baseline
Forecast for May 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹710.70
Baseline
Forecast for May 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
ASTEC Company Revenue Forecast
ASTEC Company Revenue Forecast
2026
Current
₹453.22
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2026
Current
₹453.22
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
ASTEC Stock EPS (Earnings Per Share) Forecast
ASTEC Stock EPS (Earnings Per Share) Forecast
2026
Current
₹-37.79
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹-37.79
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
ASTEC
ASTEC
Income
Balance Sheet
Cash Flow
Quarterly Normal View
ASTEC Income Statement
ASTEC Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 51.70 | 155.80 | 70.30 | 100.54 | 95.77 | 120.32 | 91.59 | 74.84 | 125.54 | 161.26 | ||||||||||
Operating & Other expenses | 69.13 | 141.04 | 115.63 | 118.28 | 99.60 | 114.00 | 102.07 | 80.41 | 122.83 | 149.46 | ||||||||||
EBITDA | -17.43 | 14.76 | -45.33 | -17.74 | -3.83 | 6.32 | -10.48 | -5.57 | 2.71 | 11.80 | ||||||||||
| Depreciation/Amortization | 8.70 | 9.01 | 9.27 | 11.47 | 11.40 | 11.58 | 11.49 | 10.44 | 11.22 | 11.77 | ||||||||||
| PBIT | -26.13 | 5.75 | -54.60 | -29.21 | -15.23 | -5.26 | -21.97 | -16.01 | -8.51 | 0.03 | ||||||||||
| Interest & Other Items | 6.09 | 6.67 | 7.04 | 9.33 | 9.92 | 10.40 | 11.04 | 8.40 | 7.17 | 7.92 | ||||||||||
| PBT | -32.22 | -0.92 | -61.64 | -38.54 | -25.15 | -15.66 | -33.01 | -24.41 | -15.68 | -7.89 | ||||||||||
| Taxes & Other Items | -7.88 | 0.05 | -21.91 | 0.02 | 15.23 | 0.42 | 0.02 | 0.02 | 0.02 | -0.14 | ||||||||||
| Net Income | -24.34 | -0.97 | -39.73 | -38.56 | -40.38 | -16.08 | -33.03 | -24.43 | -15.70 | -7.75 | ||||||||||
| EPS | -12.32 | -0.50 | -20.11 | -19.52 | -20.44 | -8.14 | -16.73 | -11.35 | -7.04 | -3.48 |
ASTEC Company Updates
ASTEC Stock Peers
ASTEC Past Performance & Peer Comparison
ASTEC Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsFertilizers & Agro Chemicals
Compare valuation on Screener
MaterialsFertilizers & Agro Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Astec Lifesciences Ltd | -19.70 | 6.78 | — |
| Fertilisers And Chemicals Travancore Ltd | 1,439.59 | 43.29 | 0.04% |
| Coromandel International Ltd | 29.58 | 5.16 | 0.56% |
| UPL Ltd | 61.28 | 1.45 | 0.92% |
ASTEC Stock Price Comparison
Compare ASTEC with any stock or ETFCompare ASTEC with any stock or ETF
ASTEC
ASTEC Holdings
ASTEC Shareholdings
ASTEC Promoter Holdings Trend
ASTEC Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ASTEC Institutional Holdings Trend
ASTEC Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ASTEC Shareholding Pattern
ASTEC Shareholding Pattern
ASTEC Shareholding History
ASTEC Shareholding History
Foreign Institutions
Mutual Funds Invested in ASTEC
Mutual Funds Invested in ASTEC
No mutual funds holding trends are available
Top 4 Mutual Funds holding Astec Lifesciences Ltd
| Funds (Top 4) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.7871% | Percentage of the fund’s portfolio invested in the stock 0.05% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 130/263 (-3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.4356% | Percentage of the fund’s portfolio invested in the stock 0.21% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 44/58 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0614% | Percentage of the fund’s portfolio invested in the stock 0.01% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 86/93 (-1) |
Compare 3-month MF holding change on Screener
smallcases containing ASTEC stock
smallcases containing ASTEC stock
Looks like this stock is not in any smallcase yet.
ASTEC Events
ASTEC Events
ASTEC Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
ASTEC Dividend Trend
No dividend trend available
ASTEC Upcoming Dividends
ASTEC Upcoming Dividends
No upcoming dividends are available
ASTEC Past Dividends
ASTEC Past Dividends
Cash Dividend
Ex DateEx DateJul 21, 2023
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 19, 2022
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 19, 2022
Cash Dividend
Ex DateEx DateJul 22, 2021
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 22, 2021
Cash Dividend
Ex DateEx DateJul 16, 2020
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 16, 2020
Cash Dividend
Ex DateEx DateJul 18, 2019
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Jul 18, 2019
ASTEC Stock News & Opinions
ASTEC Stock News & Opinions
Articles & Videos
Corporate
Astec Lifesciences to hold AGM
Astec Lifesciences announced that the 32th Annual General Meeting(AGM) of the company will be held on 31 July 2026.
1 week agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 7.76 crore in the March 2026 quarter
Net Loss of Astec Lifesciences reported to Rs 7.76 crore in the quarter ended March 2026 as against net loss of Rs 16.09 crore during the previous quarter ended March 2025. Sales rose 32.70% to Rs 158.62 crore in the quarter ended March 2026 as against Rs 119.53 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 80.92 crore in the year ended March 2026 as against net loss of Rs 134.75 crore during the previous year ended March 2025. Sales rose 17.53% to Rs 448.15 crore in the year ended March 2026 as against Rs 381.30 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales158.62119.53 33 448.15381.30 18 OPM %5.774.63 --1.01-17.36 - PBDT3.87-4.08 LP -33.99-97.27 65 PBT-7.90-15.66 50 -78.91-140.99 44 NP-7.76-16.09 52 -80.92-134.75 40 Powered by Capital Market - Live
1 week agoCapital Market - Live
Corporate
Astec Lifesciences to announce Quarterly Result
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 27 April 2026.
2 weeks agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 15.70 crore in the December 2025 quarter
Net Loss of Astec Lifesciences reported to Rs 15.70 crore in the quarter ended December 2025 as against net loss of Rs 40.38 crore during the previous quarter ended December 2024. Sales rose 32.88% to Rs 124.72 crore in the quarter ended December 2025 as against Rs 93.86 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales124.7293.86 33 OPM %3.19-6.12 - PBDT-2.37-13.75 83 PBT-13.59-25.15 46 NP-15.70-40.38 61 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Astec Lifesciences to convene board meeting
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 30 January 2026.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 24.43 crore in the September 2025 quarter
Net Loss of Astec Lifesciences reported to Rs 24.43 crore in the quarter ended September 2025 as against net loss of Rs 38.56 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales73.7298.55 -25 OPM %-9.07-20.03 - PBDT-13.97-27.07 48 PBT-24.41-38.54 37 NP-24.43-38.56 37 Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Astec Lifesciences reports standalone net loss of Rs 24.45 crore in the September 2025 quarter
Net Loss of Astec Lifesciences reported to Rs 24.45 crore in the quarter ended September 2025 as against net loss of Rs 38.57 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales73.7298.55 -25 OPM %-9.05-20.01 - PBDT-13.99-27.08 48 PBT-24.45-38.57 37 NP-24.45-38.57 37 Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Astec Lifesciences declare Quarterly Result
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 29 October 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Astec Lifesciences reports consolidated net loss of Rs 33.04 crore in the June 2025 quarter
Net Loss of Astec Lifesciences reported to Rs 33.04 crore in the quarter ended June 2025 as against net loss of Rs 39.72 crore during the previous quarter ended June 2024. Sales rose 31.30% to Rs 91.08 crore in the quarter ended June 2025 as against Rs 69.37 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales91.0869.37 31 OPM %-12.07-66.67 - PBDT-21.52-52.37 59 PBT-33.02-61.64 46 NP-33.04-39.72 17 Powered by Capital Market - Live
9 months agoCapital Market - Live
Corporate
Astec Lifesciences schedules board meeting
Astec Lifesciences will hold a meeting of the Board of Directors of the Company on 28 July 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of -6.26%, vs industry avg of 9.41%
Over the last 5 years, market share decreased from 0.38% to 0.17%